Page last updated: 2024-09-03

nnc 711 and 3-aminopropylphosphinic acid

nnc 711 has been researched along with 3-aminopropylphosphinic acid in 1 studies

Compound Research Comparison

Studies
(nnc 711)
Trials
(nnc 711)
Recent Studies (post-2010)
(nnc 711)
Studies
(3-aminopropylphosphinic acid)
Trials
(3-aminopropylphosphinic acid)
Recent Studies (post-2010) (3-aminopropylphosphinic acid)
1120213002

Protein Interaction Comparison

ProteinTaxonomynnc 711 (IC50)3-aminopropylphosphinic acid (IC50)
Gamma-aminobutyric acid type B receptor subunit 2Rattus norvegicus (Norway rat)0.0052
Gamma-aminobutyric acid type B receptor subunit 1Rattus norvegicus (Norway rat)0.0051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kerr, DI; Ong, J1

Other Studies

1 other study(ies) available for nnc 711 and 3-aminopropylphosphinic acid

ArticleYear
The gamma-aminobutyric acid uptake inhibitor NO-711 potentiates 3-aminopropylphosphinic acid-induced actions in rat neocortical slices.
    European journal of pharmacology, 1998, Apr-24, Volume: 347, Issue:2-3

    Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Electrophysiology; GABA Agonists; GABA Antagonists; In Vitro Techniques; Male; Neocortex; Nipecotic Acids; Organophosphorus Compounds; Oximes; Rats; Rats, Sprague-Dawley

1998